Casey C Smith alias The Metabolic Adjuster

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Fibromyalgia.

Fibromyalgia

Supports

There are some small randomized and nonrandomized clinical trials suggesting that chiropractic or spinal manipulation as part of a multimodal program may improve pain, function, or range of motion in fibromyalgia, but these are preliminary and often methodologically weak. ^[2][11] Narrative and umbrella reviews identify several RCTs (e. g. , spinal manipulation added to exercise or multimodal programs, upper cervical manipulation trials) that report improvements in fibromyalgia outcomes over time, which provides limited, low-quality support for the possibility of benefit. ^[4][6][9] A randomized trial combining resistance training with chiropractic care found that adding chiropractic improved exercise adherence and dropout rates and was associated with greater improvements in certain functionality domains, suggesting chiropractic might have an adjunctive role rather than being a primary fibromyalgia treatment. ^[10][12]

Contradicts

Multiple systematic reviews and evidence overviews conclude that the evidence for chiropractic or spinal manipulation in fibromyalgia is weak, inconsistent, and methodologically poor, and that there is no reliable proof it is effective as a stand‑alone treatment. ^{[4][9][11][12]} A systematic review of chiropractic treatment for fibromyalgia identified only three small, poor‑quality studies and found no evidence that chiropractic care is effective for fibromyalgia pain or global symptoms. ^[10] An overview of systematic reviews of complementary and alternative medicine for fibromyalgia reports that no firm conclusions can be drawn for spinal manipulation and that existing chiropractic trials do not demonstrate clear pain benefit. Large evidence reports on manual therapies and spinal manipulation characterize the evidence for fibromyalgia as inconclusive and in an unclear direction, with low quantity and poor quality of primary data. ^[6] A more recent systematic review of manual therapy in fibromyalgia similarly judges the overall quality of evidence as very low to moderate and concludes it is insufficient to support or recommend manual therapy for this condition. ^[7] Sham‑controlled osteopathic manipulation trials in fibromyalgia, which are conceptually similar manual therapies, show no clinically meaningful benefit over sham in pain, fatigue, function, or quality of life, reinforcing concerns that any apparent benefit of hands‑on manipulative approaches may largely reflect expectancy, placebo, or nonspecific effects rather than specific efficacy. Overall, high‑quality evidence contradicts any strong claim that chiropractic treatment is an effective primary therapy for fibromyalgia.

Mainstream view

Mainstream medical and scientific opinion is that fibromyalgia is best managed with a multimodal approach centered on patient education, aerobic and strengthening exercise programs, cognitive‑behavioral or other psychological therapies, and judicious use of medications with evidence for benefit (e. g. , certain antidepressants, anticonvulsants, or other agents), usually following rheumatology and pain society guidelines. ^[2] Chiropractor‑delivered spinal manipulation or other manual therapies are not considered first‑line or core evidence‑based treatments for fibromyalgia, and are generally viewed—at most—as optional complementary interventions that might help some individuals but lack robust, high‑quality evidence of specific efficacy. ^[1][9] Current systematic reviews and evidence syntheses assess the quality of evidence for chiropractic in fibromyalgia as low and inconclusive, and major guidelines do not endorse chiropractic manipulation as a standard treatment for this condition. ^{[4][6][10][11][12]}

In their own wordsView sourceArchived copy

“Fibromyalgia”

Rule: Minn. Stat. § 148.01, subd. 1(4), (5), and (9)

See every doc bro advertising Chronic fatigue and fibromyalgia

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid Relief.

Thyroid Relief

Supports

There are no randomized controlled trials, systematic reviews, or major clinical guidelines showing that chiropractic spinal manipulation or other chiropractic techniques improve thyroid function, cure hypothyroidism, or provide specific “thyroid relief” beyond general musculoskeletal symptom management. ^[2][16] A randomized, parallel, blinded multicenter trial of Neuro-Emotional Technique (a chiropractic-associated biopsychosocial intervention) in people with primary hypothyroidism found no statistically or clinically significant changes in thyroid-related or other primary outcomes compared with placebo, and concluded that the intervention “did not confer any clinical benefit” and is unlikely to be of therapeutic use in a hypothyroid population. ^[13][14][15] Systematic reviews of spinal manipulation report only low-quality evidence for short-term autonomic or biochemical changes (for example, transient cortisol or other biochemical marker changes), but these are not linked to durable or clinically meaningful improvements in endocrine diseases such as thyroid disorders. ^[6] Case reports and small uncontrolled series describe individual patients whose thyroid hormone dose was reduced or whose thyroid-related symptoms improved during chiropractic care, but these are anecdotal, subject to multiple biases, and do not constitute high-quality evidence. Mainstream thyroid RCTs (for example, comparing levothyroxine alone versus levothyroxine plus liothyronine) focus on pharmacologic hormone replacement and show cardiovascular or symptomatic effects of adjusting hormone therapy, not effects of chiropractic care. ^[7]

Contradicts

The best available direct trial evidence in hypothyroidism contradicts the notion that a chiropractic-style biopsychosocial technique meaningfully treats thyroid disease: a multicenter, randomized, placebo-controlled trial of Neuro-Emotional Technique in adults with primary hypothyroidism showed no significant differences between intervention and placebo groups on primary or secondary outcomes at 7 weeks or 6 months, and concluded that NET did not provide clinical benefit in this hypothyroid population. ^{[2][3][13][14][15]} High-level overviews of spinal manipulation indicate that, overall, there is little convincing evidence that spinal manipulation is an effective treatment for medical conditions beyond certain musculoskeletal pain syndromes, and emphasize that the quality of evidence for systemic or disease-modifying effects is low. ^[4][6] Systematic reviews of autonomic and biochemical responses to spinal manipulation find at most low-quality evidence for short-term changes in autonomic markers or cortisol and inflammatory markers, with no demonstrated translation into improved outcomes for chronic systemic diseases such as thyroid disorders. ^[16] No endocrine or thyroid management guidelines endorse chiropractic or spinal manipulation as a treatment for hypothyroidism, hyperthyroidism, thyroiditis, or thyroid cancer–related hormone issues; standard care remains pharmacologic thyroid hormone replacement, radioactive iodine or surgery when indicated, and monitoring. ^[5] Large, evidence-based guidelines in other medical domains (for example, hypertension and nutrition guidelines) demonstrate how strong recommendations are based on robust RCT and cohort data, underscoring that similar high-quality evidence is lacking for chiropractic treatment of thyroid disease. ^[1]

Mainstream view

The mainstream medical position is that thyroid disorders (hypothyroidism, hyperthyroidism, thyroiditis, and most thyroid cancer–related hormonal problems) are endocrine diseases that are diagnosed and managed using established pharmacologic, surgical, and sometimes radioactive iodine therapies, not chiropractic manipulation. Standard treatment for hypothyroidism is lifelong levothyroxine dose-adjusted to normalize thyroid-stimulating hormone and free thyroid hormone levels; for hyperthyroidism, antithyroid drugs, radioactive iodine, or surgery are used depending on etiology. Major evidence-based guidelines and randomized trials in thyroid disease focus on optimizing hormone replacement regimens, cardiovascular safety, and symptom control, and do not include chiropractic care as a recommended therapy. ^[1][2][6][7] An RCT of a chiropractic-associated biopsychosocial intervention (Neuro-Emotional Technique) in primary hypothyroidism showed no clinical benefit compared with placebo, reinforcing the view that such interventions do not treat thyroid failure itself. ^[14] Systematic reviews of spinal manipulation report low-quality, short-term autonomic or biochemical effects that have not been shown to translate into clinically meaningful improvements in endocrine outcomes, and comprehensive reviews do not support spinal manipulation as an effective treatment for non-musculoskeletal medical conditions. ^[4][16] Chiropractors may help some patients with neck, back, or generalized musculoskeletal pain that co-exists with thyroid disease, but this is considered supportive, symptomatic care and not a treatment for the underlying thyroid disorder. ^[13][15]

In their own wordsView sourceArchived copy

“Thyroid Relief”

Rule: Minn. Stat. § 148.01, subd. 1(1), (2), and (9)

See every doc bro advertising Thyroid disease and Hashimoto

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure neuropathy.

neuropathy

Supports

There is very limited high-quality evidence directly assessing chiropractic treatment for peripheral neuropathy. ^[6] Existing controlled trials and systematic reviews on chiropractic spinal manipulative therapy (SMT) focus mainly on spine pain (low back pain, neck pain, migraine), not on primary peripheral neuropathies. ^{[7][17][18][19][20]} A mechanistic rat and human study suggests that spinal manipulative therapy can reduce peripheral neuropathic leg pain and modulate pain pathways, but this is preclinical/early-stage and not definitive clinical evidence for neuropathy treatment in humans. ^[2] Some evidence exists for non-pharmacologic, physical treatment approaches (such as neural mobilisation and neuromuscular training) improving nerve conduction and neuropathic symptoms in specific contexts, but these are not chiropractic SMT per se and often come from physiotherapy or exercise-based interventions, not chiropractic care. Overall, there is no major guideline or high-quality systematic review that clearly supports chiropractic manipulation as an evidence-based primary treatment for peripheral neuropathy. ^[1][4]

Contradicts

Major clinical practice guidelines for neuropathic pain and peripheral neuropathy do not list chiropractic spinal manipulation as a standard, recommended treatment; they instead emphasize pharmacologic therapies, disease-specific management (e. ^{[2][3][19][20]} g. , glycemic control in diabetes), physical therapy, and in some cases neuromodulation or structured exercise programs. ^[7] Where high-quality evidence exists for neuropathy (e. g. , diabetic peripheral neuropathy, chemotherapy-induced neuropathy), it focuses on medications, neuromuscular training, compression or cryotherapy, spinal cord stimulation, acupuncture, and other modalities, not chiropractic SMT. Systematic reviews of SMT indicate that for spine pain the efficacy of SMT versus sham or placebo remains uncertain and that SMT is not clearly superior to other conventional interventions, which indirectly argues against strong claims that SMT can reliably treat neuropathic conditions. ^[18] Evidence for neural mobilisation and similar manual therapies in neuropathic pain is graded as low to moderate quality and is largely limited to short-term improvements in specific measures, suggesting that manual techniques may have some effect but the data are weak and not specific to chiropractic practice. Overall, the evidence base for chiropractic treatment of neuropathy is sparse, low-quality, and indirect, and strong claims of efficacy are not supported by randomized trials or major guidelines. ^[4][6][17]

Mainstream view

The mainstream medical view is that peripheral neuropathy should be managed according to its cause (e. g. , diabetes, chemotherapy, autoimmune disease, compression neuropathies) using established evidence-based strategies: risk factor control, pharmacologic agents for neuropathic pain, physical therapy, neuromuscular or sensorimotor training, and selected non-pharmacologic modalities that have randomized trial support. ^{[1][7][17][20]} Chiropractic spinal manipulation is sometimes used as an adjunct for musculoskeletal pain (especially back and neck pain), but it is not regarded as an established or guideline-recommended primary treatment for peripheral neuropathy. ^[4][19] Use of chiropractic care for neuropathy is therefore considered experimental or complementary, with insufficient high-quality evidence to endorse it as a standard therapy. ^[6] Patients with neuropathy are typically advised to be evaluated by clinicians experienced in neurology, endocrinology, oncology, or pain medicine, and to use chiropractic or other manual therapies only, if at all, as adjuncts within a broader, medically supervised treatment plan. ^[18]

In their own wordsView sourceArchived copy

“[](https://www.askdrsmith.com/neuropathy-center/)”

Rule: Minn. Stat. § 148.01, subd. 1(4), (5), and (9)

See every doc bro advertising Neuropathy

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure carpal tunnel.

carpal tunnel

Supports

For chronic spinal pain, there is randomized controlled trial evidence that chiropractic treatment combined with ergonomic advice can reduce pain grade and improve quality of life in people with chronic spinal pain, which supports a role for chiropractic in some forms of chronic musculoskeletal pain . ^[22] Broader systematic reviews and meta-analyses of spinal manipulative therapy (a core component of chiropractic care) for chronic low back pain show that it can provide pain and disability improvements similar to other recommended therapies such as exercise, although generally not superior to them, which partly supports the claim that chiropractic may help some chronic pain conditions. ^[23] For migraine and headache, randomized controlled trials show that spinal manipulative or multimodal chiropractic care can lead to modest reductions in migraine days and headache parameters compared with usual care or placebo in some studies, suggesting possible benefit for a subset of patients, but these trials are small and feasibility-focused rather than definitive. ^[21][24] Qualitative and observational work reports that some patients with migraine perceive chiropractic care as helpful for pain management and quality of life, which is consistent with limited clinical trial findings but does not constitute strong efficacy evidence .

Contradicts

For migraine and headaches, up-to-date systematic reviews of spinal manipulations for migraine conclude that the effectiveness of spinal manipulative therapy remains unproven and that, based on very low-quality evidence, it cannot be considered an evidence-based therapy for this condition, directly contradicting broad claims that chiropractic can treat migraines and headaches in a robust, reliable way. ^[21][22][23] Earlier systematic reviews similarly report that current evidence does not support recommending spinal manipulations for migraine headaches, highlighting poor methodological quality and inconsistent results across randomized trials. For carpal tunnel syndrome, a systematic review of chiropractic manipulation for carpal tunnel found only one low-quality trial and judged that there is insufficient evidence to suggest chiropractic is effective for treating carpal tunnel, contradicting claims that chiropractic is an established treatment for this condition . Comparative randomized trials of chiropractic care versus conservative medical care for carpal tunnel show overall improvement in both groups but no significant differences between them, indicating that chiropractic is not superior and that evidence for specific efficacy is weak. ^[24] Across conditions, major evidence syntheses on spinal manipulative therapy emphasize that benefits for chronic pain are modest, often similar to other conservative care, and that the quality of evidence for non-spinal conditions like carpal tunnel or for headache disorders is low, so strong claims that chiropractic can treat a “wide variety” of such issues overstate what the data support.

Mainstream view

The mainstream medical and scientific position is that chiropractic/spinal manipulative therapy may be considered as an option for certain chronic musculoskeletal pain conditions (especially low back and neck pain) where evidence shows modest benefits comparable to other conservative treatments, but it is not viewed as a primary or highly effective treatment for migraine, tension-type headaches, or carpal tunnel syndrome. ^{[21][22][23][24]} For migraine and recurrent headaches, pharmacologic therapies, lifestyle modification, and evidence-based nonpharmacologic approaches (such as some forms of physical therapy, cognitive-behavioral interventions, and biofeedback) are preferred, and spinal manipulation/chiropractic is at most an adjunct, with guideline bodies generally not recommending it as first-line therapy due to limited and low-certainty evidence. For carpal tunnel syndrome, mainstream management emphasizes activity modification, splinting, steroid injections, and, for more severe cases, surgical decompression; chiropractic manipulation is not considered an evidence-based standard treatment and is rarely included in high-quality guidelines. Overall, experts consider chiropractic appropriate mainly for spinal musculoskeletal complaints, with cautious, case-by-case use, and regard claims that it can treat a wide spectrum of conditions like migraines, chronic non-spinal pain, and carpal tunnel as going beyond the strength and scope of current evidence.

In their own wordsView sourceArchived copy

“[](https://www.askdrsmith.com/carpal-tunnel/)”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure telemed.

telemed

Supports

The influencer’s claim is very vague, but if interpreted as “chiropractic care can be delivered effectively via telemedicine,” there is some emerging evidence that telehealth approaches can be used for musculoskeletal assessment and management, including by chiropractors, and that outcomes such as pain, function, and satisfaction can be comparable to in‑person care in selected situations. ^[1][6][26] High-quality musculoskeletal telehealth evidence (mostly in physical therapy/rehabilitation rather than chiropractic specifically) shows that virtual physical therapy is noninferior to conventional in‑person therapy for several musculoskeletal disorders, and structured telemedicine-supported exercise programs can improve disability and pain in chronic low back pain, indicating that remote, exercise-focused care can be effective when appropriately designed and supervised. ^[5][7][25] Telehealth musculoskeletal assessment frameworks and systematic reviews report moderate to high diagnostic agreement between telehealth and in‑person assessments for certain musculoskeletal conditions, supporting the feasibility of remote triage and follow-up when hands-on examination is not critical. ^[4][28] General telemedicine RCTs in other fields (e. g. , cardiac rehabilitation, asthma, depression, hepatitis C) demonstrate that telemedicine-delivered care can be as effective as or better than traditional models for some outcomes, indirectly supporting the concept that clinician-led care—including nonpharmacologic, behavioral, and exercise-based interventions—can be safely and effectively delivered via telemedicine when protocols and infrastructure are robust.

Contradicts

There is very limited high-quality, condition-specific evidence that chiropractic telemedicine alone (without in-person visits) is equivalent to standard in-person chiropractic care, particularly for interventions that are inherently manual (spinal manipulation and other hands-on techniques). ^[6] Existing chiropractic telehealth reports are largely descriptive or observational, focusing on rapid deployment during COVID-19 and feasibility, and they explicitly note that the efficacy and effectiveness of chiropractic telehealth services have yet to be determined. ^[26] Systematic reviews of musculoskeletal telehealth highlight that evidence quality is often low, heterogeneous, and not easily generalizable, with mixed results and uncertainty, so broad claims that telemedicine-based chiropractic care is fully equivalent to traditional care across conditions are not supported. ^[1] Many musculoskeletal and telemedicine guidelines emphasize that telehealth is appropriate for triage, follow-up, education, and exercise-based management, but that patients with red flags, deformity, or neurovascular compromise, or when diagnosis is uncertain, should be seen in person, which contradicts any implication that telemedicine can universally replace in-person chiropractic evaluation and treatment. ^{[2][5][25][28]} Overall, there is a clear evidence gap for rigorously tested chiropractic-specific telemedicine RCTs and long-term outcome data, so strong claims about its effectiveness or superiority go beyond the current evidence base.

Mainstream view

The mainstream medical and scientific position is that telemedicine is a valuable adjunct for musculoskeletal care and can be safely and effectively used for triage, education, exercise prescription, and follow-up in appropriately selected patients, but it does not fully replace in-person assessment and treatment, particularly for conditions requiring detailed physical examination or hands-on procedures. ^[4][28] For chiropractic practice, telemedicine is viewed as a way to provide remote consultations, screening, self-management advice, and exercise or lifestyle counseling, while reserving manual therapies for in-person visits. Major musculoskeletal and telehealth guidance generally supports a blended or hybrid care model, with telemedicine integrated into broader clinical pathways and clear criteria for when in-person assessment is required. ^[2][5][25] Because robust randomized trials and high-certainty evidence specifically for chiropractic telemedicine are scarce, mainstream opinion considers chiropractic telehealth promising but still experimental or developing, and recommends cautious, evidence-informed use rather than broad claims of equivalence to traditional hands-on chiropractic care. ^[26]

In their own wordsView sourceArchived copy

“[](https://www.askdrsmith.com/telemed)”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure weight loss.

weight loss

Supports

There is almost no high-quality evidence that chiropractic spinal manipulation by itself produces clinically meaningful weight loss. The few data points involve chiropractic clinics delivering broader lifestyle programs. A retrospective file review of a 13‑week multimodal weight loss program run in a chiropractic practice (spinal manipulation plus diet, exercise, and counseling) found significant reductions in weight and BMI, but this was an uncontrolled chart review with only 16 completers out of 30 and cannot isolate any effect of chiropractic treatment itself.^[5] A secondary analysis of chiropractor-directed weight-loss interventions in Canada found that some chiropractors do provide guideline-consistent advice on weight management and lifestyle, but it did not demonstrate that chiropractic care independently causes weight loss.^[7] Overall, existing evidence supports that weight loss can occur when standard diet and exercise programs are delivered in a chiropractic setting, not that chiropractic manipulation is an active weight-loss treatment.

Contradicts

High-quality evidence for effective weight loss consistently comes from interventions based on diet, physical activity, behavioral counseling, pharmacotherapy (e.g., GLP‑1 receptor agonists), and bariatric surgery, not from chiropractic manipulation. Large randomized controlled trials and systematic reviews of weight-loss strategies show clinically meaningful weight reduction with energy restriction, structured diet and exercise, digital/behavioral programs, and drugs like GLP‑1 receptor agonists, often achieving 5–15% body-weight loss or more, whereas no comparable randomized trials exist for chiropractic manipulation as a primary weight-loss modality.^{[19][20][21][24]} A systematic review of systematic reviews of spinal manipulation concluded there was no convincing evidence that spinal manipulation is an effective treatment for any medical condition, and therefore it is not generally recommendable as a primary therapy.^[5][11] Major guidelines for nutrition support, chronic disease management, and obesity-related comorbidities (e.g., ASPEN and ESPEN guidelines) focus on nutritional strategies, medical therapy, and in some cases surgery, and do not recommend chiropractic manipulation as a treatment for overweight or obesity.^{[1][2][3][4][5]} The absence of chiropractic in evidence-based obesity guidelines and the lack of RCTs directly testing chiropractic for weight loss strongly contradict any claim that chiropractic treatment itself is a validated weight-loss therapy.

Mainstream view

Mainstream medical and scientific consensus is that obesity and weight management should be addressed through evidence-based lifestyle interventions (calorie reduction, physical activity, behavioral therapy), pharmacologic agents when indicated, and bariatric surgery for selected patients, underpinned by guideline-based nutritional and medical management.^{[1][2][3][19]} Spinal manipulation or chiropractic adjustment is not recognized in major obesity or nutrition guidelines as an effective or recommended treatment for weight loss, and any role for chiropractors in this area is limited to providing general lifestyle counseling similar to that offered in other primary care settings. Current evidence therefore supports the view that chiropractic care may be a setting in which standard weight-loss strategies are delivered, but chiropractic manipulation itself is not an established or recommended weight-loss treatment.

In their own wordsView sourceArchived copy

“[](https://www.askdrsmith.com/weight-loss/)”

Rule: Minn. Stat. § 148.01, subd. 1(6) and (9)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise wellness care as within their scope of practice.

wellness care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“[](https://www.askdrsmith.com/wellness-care/)”

Rule: Minn. Stat. § 148.01, subd. 1(6) and (9)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure headaches/migraines.

headaches/migraines

Supports

There are randomized controlled trials suggesting that chiropractic spinal manipulative therapy (SMT) may reduce migraine frequency, duration, disability, and medication use compared with control or sham interventions, although most are small and methodologically limited. ^[7][22][23] A 2019 meta-analysis of six RCTs (n≈677) reported that spinal manipulation may reduce migraine days and pain/intensity, with pooled effect sizes favoring SMT, but explicitly labeled the evidence as preliminary and called for larger, more rigorous trials. ^[6][34] Some RCTs of multimodal chiropractic care (manipulation plus education/exercise and other components) in episodic migraine show a modest additional reduction in migraine days versus enhanced usual medical care alone, again as secondary outcomes in pilot trials. For tension-type and cervicogenic headache, a systematic review of RCTs on spinal manipulation for tension-type headaches found that several trials suggested SMT was more effective than usual care, drug therapy, or sham manipulation, although overall conclusions were that evidence was encouraging but inconclusive. ^[33] A 2011 evidence-based chiropractic guideline concluded that chiropractic care including spinal manipulation can improve migraine and cervicogenic headaches and recommended spinal manipulation and multimodal care (including massage) for episodic and chronic migraine, while acknowledging the limitations of the evidence base. ^[1] An EFNS guideline on the treatment of tension-type headache focuses on pharmacologic management but does acknowledge that various non-pharmacologic and manual therapies are used as adjuncts, which is consistent with, but does not strongly endorse, SMT for these headaches as primary therapy. ^[4]

Contradicts

A recent updated systematic review and meta-analysis (2024) of spinal manipulation for migraine concluded that compared with placebo, drug therapy, or usual care, SMT had no clinically important effect on migraine intensity, duration, frequency, or disability and that the effectiveness of SMT for migraine remains unproven due to very low-certainty evidence. ^{[7][22][23][33][34]} This review explicitly stated that SMT cannot be considered an evidence-based therapy for migraine at this time. ^[1] Earlier systematic reviews of spinal manipulation for headache disorders (including migraine and tension-type headache) have consistently highlighted serious limitations: small sample sizes, risk of bias (inadequate blinding, poor allocation concealment), heterogeneity of techniques and comparators, and short follow-up periods. For tension-type headache, the 2012 systematic review judged the data as encouraging but inconclusive and emphasized that the low quantity and quality of trials prevent firm conclusions, contradicting any strong claim of established efficacy. Several headache and neurology society guidelines that concentrate on evidence-based treatments for migraine and tension-type headache either do not recommend chiropractic SMT or at most mention manual therapies as optional adjuncts with limited or low-quality evidence, and they prioritize pharmacologic prophylaxis and acute treatments (such as triptans, gepants, CGRP monoclonal antibodies, and standard analgesics) as first-line therapies. ^[2][6] Overall, higher-quality and more recent evidence syntheses tend to downgrade the role of SMT for migraine to uncertain/unsupported, and even for tension-type headache they describe SMT as a possible adjunct with insufficient evidence rather than a proven treatment. ^[4]

Mainstream view

Mainstream medical and scientific opinion is that chiropractic spinal manipulation is not an evidence-based first-line treatment for migraine and has, at best, limited and low-certainty evidence as an adjunctive therapy for some headache types. ^{[1][7][22][23][33][34]} Neurology and headache society guidelines emphasize pharmacologic treatments and certain behavioral therapies (e. ^[2] g. , cognitive-behavioral therapy, relaxation training, biofeedback) as standard care for migraine and tension-type headache, with manual therapies, including chiropractic SMT, seen as optional complementary approaches when patients prefer non-drug strategies or have contraindications, and only after appropriate medical evaluation to rule out secondary causes of headache. ^[4][5] For tension-type and cervicogenic headaches, mainstream views accept that manual therapy (which may include spinal manipulation and mobilization) can be part of a multimodal regimen but stress that the evidence quality is modest and that benefits appear small to moderate at best. ^[6] Major guidelines and recent systematic reviews emphasize that available SMT trials are small, at risk of bias, and insufficient to support claims that chiropractic treatment is broadly effective for headaches or migraines; they call for larger, methodologically rigorous RCTs before SMT can be recommended as a standard treatment. Safety considerations are also important: while serious adverse events after cervical manipulation are rare, they include cervical artery dissection and stroke, so most mainstream experts recommend that any use of SMT for headaches be carefully weighed against established, lower-risk therapies and integrated into care rather than used as sole treatment.

In their own wordsView sourceArchived copy

“[](https://www.askdrsmith.com/headaches-migraines/)”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure our neurologic and metabolic assessment and care.

our neurologic and metabolic assessment and care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Through our neurologic and metabolic assessment and care, we move beyond treating symptoms to identifying and treating their sources, in order to restore a healthier more vibrant lifestyle!”

Rule: Minn. Stat. § 148.01, subd. 1(4), (5), and (9)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to diagnose, treat, or cure Specific Neurological Testing to develop your customized Neurological Treatments.

Specific Neurological Testing to develop your customized Neurological Treatments

Supports

There is a growing precision neurology / precision medicine literature describing the use of detailed diagnostic testing (genetic, biomarker, neuroimaging, electrophysiologic, and behavioral data) to stratify patients and guide more individualized treatment plans in neurology. ^[4][35][36] Reviews of precision neurology explicitly define prevention and treatment strategies that take individual variability in clinical, genetic, and biological features into account to tailor therapies to the person, which conceptually supports individualized neurological interventions based on specific testing. ^[2] Several areas show concrete, though still emerging, translation into practice: for example, genetic testing in amyotrophic lateral sclerosis is now covered by evidence-based guidelines that recommend routine genetic testing to help inform diagnosis, prognosis, and consideration of targeted therapies in some patients, representing a test-to-treatment link. ^[1][6] In developmental and epileptic encephalopathies, precision therapies such as antisense oligonucleotides, gene therapies, and targeted small molecules are being developed specifically for genetically defined subtypes, making the neurological testing (comprehensive genetic analysis) central to selecting the appropriate treatment. ^[5] Reviews of comprehensive genetic analysis in neurology emphasize that selecting the appropriate genetic test can clarify diagnosis and is increasingly used for personalized management, supporting the general idea that neurologic (often genetic) testing can guide individualized treatment strategies. ^[37] There are also emerging RCTs and controlled studies of personalized neuromodulation or neurofeedback protocols (for example, stroke-related personalized tDCS or individualized neurofeedback in cognitive impairment) where parameters are individualized based on patient-specific biomarkers or neurophysiology, suggesting that in some niches, specific neurological testing is already being used to customize interventions, although this is still largely experimental. ^[38]

Contradicts

The influencer’s claim is extremely broad and non-specific, and the current evidence base does not support a generic promise that “specific neurological testing” will reliably yield effective, fully customized neurological treatments for most neurological conditions. ^[6] Precision neurology is described in high-quality reviews as an emerging paradigm, with major challenges including limited clinical implementation, high testing costs, uncertain cost‑effectiveness, and lack of robust outcome data across diverse populations. ^[2][35][36] Many precision approaches in neurology, such as complex multi-omic testing and advanced neurogenomics workflows, are still largely research tools used to generate hypotheses rather than standard-of-care clinical interventions with proven outcome benefits from RCTs. ^[37] Even where testing is advanced (e. g. , broad genetic panels or multi-omic workflows), reviews emphasize the need for further research and better evidence before widespread adoption as routine individualized treatment decision tools, which contradicts any implication that such customized neurological treatments are already well-established and broadly effective in everyday practice. Existing randomized trials of individualized neuromodulation or precision-style multimodal programs tend to be small, condition-specific, and preliminary; they do not justify sweeping claims that any patient can receive reliably effective customized neurological treatment simply by undergoing unspecified “specific neurological testing. ” In addition, conventional neurology guidelines (e. g. , for common conditions like tension-type headache) continue to recommend standardized, population-based treatments and do not endorse broad “wide-net” neurological testing batteries or highly individualized protocols for routine care, indicating that mainstream practice remains largely guideline- and population-evidence-based rather than built around extensive individualized neurological test panels. ^[1][4]

Mainstream view

Mainstream neurology supports targeted use of neurological tests (neuroimaging, electrophysiology, laboratory tests, and when indicated, genetic testing) to establish or refine diagnoses and to choose among evidence-based treatments, but it does not endorse routine broad “specific neurological testing” panels as a universal pathway to highly customized treatments for every patient or condition. ^[1][5] Precision neurology and personalized medicine are recognized as important and rapidly developing fields, with clear examples where specific testing directly guides tailored interventions (notably in certain genetic epilepsies, neurogenetic disorders, and some neuromuscular and neurodegenerative diseases), yet authoritative reviews consistently describe these as emerging approaches that are not yet widely implemented as standard care across neurology. ^[35][36][37] Current major guidelines for common neurological disorders still emphasize standardized, evidence-based therapeutic algorithms, sometimes with modest personalization (e. ^[2][6] g. , comorbidities, age, risk factors, patient preferences), and they typically recommend focused, hypothesis-driven testing rather than indiscriminate broad testing batteries. The mainstream position is therefore that individualized neurological treatment informed by specific tests is appropriate in selected contexts, particularly where robust evidence connects a test result to a specific therapeutic choice, but broad marketing claims of “specific neurological testing to develop your customized neurological treatments” overstate the current maturity, scope, and evidence base of precision neurology as a universal clinical service. ^[4]

In their own wordsView sourceArchived copy

“Specific Neurological Testing to develop your customized Neurological Treatments”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise Getting comprehensive Lab testing and implementing Metabolic Treatments designed for you as within their scope of practice.

Getting comprehensive Lab testing and implementing Metabolic Treatments designed for you

Supports

High-quality evidence supports the general concept of precision medicine, where laboratory and biomarker testing are used to tailor treatments to individual metabolic and biological characteristics, particularly in defined diseases such as metabolic syndrome, obesity, depression, and cancer. Precision medicine frameworks explicitly state that integrating genetics, biomarkers, metabolomics, and other lab-based profiles allows more accurate risk assessment, diagnosis, and individualized treatment decisions, improving outcomes compared with one‑size‑fits‑all approaches.^{[16][18][19][20]} Metabolomics and metabolic profiling are described as key tools in precision health and precision medicine, enabling identification of metabolic biomarkers, defining individual “metabotypes,” and monitoring treatment response, all of which underpin metabolically targeted therapies.^{[10][11][14][19][20]} Personalized nutrition and metabolic testing approaches in obesity and metabolic disorders use resting metabolic rate, thermic effect of food, and respiratory quotient measurement to set individualized calorie and macronutrient prescriptions, with emerging evidence that such testing can optimize weight‑loss and maintenance strategies and improve metabolic outcomes.^[12][13][15] Precision medicine in metabolic syndrome uses integrated lab testing (genomic, metabolic, and classical labs) to stratify risk, personalize lifestyle and pharmacologic interventions, and support earlier detection and more tailored treatment, suggesting that lab‑guided metabolic interventions can improve prevention and management at least in high‑risk or affected populations.^[16] In oncology, comprehensive genomic and molecular profiling plus tumor boards to interpret lab data have been associated with improved progression‑free survival and better clinical outcomes compared with non‑profile‑guided treatment, indicating that extensive lab‑based profiling can meaningfully guide personalized therapy in specific diseases.^[3][5][6][8] Ketogenic metabolic therapies use specific metabolic biomarkers (β‑hydroxybutyrate, HbA1c, fasting glucose, insulin) to individualize dietary and treatment adjustments, and clinical data show improvements in glycemic and weight‑related markers when these biomarker‑guided metabolic treatments are correctly implemented.^[4][17] Overall, there is solid support for targeted, disease‑specific metabolic and laboratory testing as part of precision medicine strategies, when applied to clearly defined conditions and within structured clinical protocols and guidelines.^{[16][18][19][20]}

Contradicts

The claim as stated is extremely broad and implies that “getting comprehensive lab testing” and implementing “metabolic treatments designed for you” is generally beneficial for health, which is not supported by high‑quality evidence for asymptomatic, otherwise healthy adults. Population‑level data and guideline‑based syntheses indicate that routine “comprehensive” testing (large wellness panels, broad biomarker batteries without clear indications) does not improve mortality or major health outcomes and carries risks of overdiagnosis, incidental findings, unnecessary follow‑up, and anxiety; mainstream preventive recommendations instead call for minimal, age‑ and risk‑based lab screening rather than broad panels in healthy adults.^[22][23][24] Precision medicine literature emphasizes that metabolic and biomarker testing should be problem‑driven (e.g., metabolic syndrome, obesity, diabetes, cancer, depression), with defined clinical pathways for how test results will change management; evidence for benefit is concentrated in such specific, high‑risk or disease populations and does not extend to indiscriminate comprehensive testing in the general population.^{[16][18][19][20]} Current precision‑health and metabolomics reviews highlight that while metabolomics and metabolic profiling are promising, many applications remain in research or early clinical integration; robust randomized trials showing that broad metabolic testing plus bespoke metabolic interventions improve hard outcomes (mortality, major cardiovascular events) in unselected adults are limited or absent.^{[10][11][14][19][20]} Even in conditions like obesity and metabolic syndrome, metabolic testing to personalize treatment is described as an emerging or adjunctive strategy rather than a universally recommended standard of care, reflecting that the evidence base is still developing and not yet strong enough to justify widespread comprehensive testing for all.^{[12][13][15][16]} Some clinical contexts show that chemotherapy and other treatments can induce metabolic disturbances and metabolic syndrome, but the response there is targeted monitoring and risk‑based metabolic management, not blanket comprehensive lab panels, underscoring that metabolic care is problem‑focused rather than broadly applied to everyone.^[7][16] Overall, while disease‑specific precision metabolic approaches are supported, the influencer‑style implication that any person will benefit from extensive lab panels and bespoke metabolic protocols lacks strong trial‑level evidence and conflicts with mainstream recommendations against unnecessary broad screening in healthy individuals.^[22][23][24]

Mainstream view

The mainstream medical position is that precision medicine, including lab‑guided metabolic and biomarker‑based personalization, is ^{[39][40][41][42]}

In their own wordsView sourceArchived copy

“Getting comprehensive Lab testing and implementing Metabolic Treatments designed for you”

Rule: Minn. Stat. § 148.01, subd. 1(4), (5), (6), and (9)

Casey C Smith is not licensed or approved by Minnesota Board of Chiropractic Examiners to advertise move beyond treating symptoms to identifying and treating their sources as within their scope of practice.

move beyond treating symptoms to identifying and treating their sources

Supports

High-quality clinical guidelines generally emphasize diagnosing and addressing underlying disease processes and risk factors rather than only suppressing symptoms, which supports the general thrust of the claim. ^[2] Hypertension guidelines stress guideline-driven, etiologic and risk-factor–focused management (e. ^[1] g. , blood pressure control, lifestyle, comorbidity management) rather than mere relief of symptoms like headache or dizziness. Evidence-based nutrition guidelines for conditions such as critical illness and inflammatory bowel disease similarly recommend assessing and treating underlying malnutrition, inflammation, and disease activity instead of using nutrition solely for short-term comfort. ^[3][5][43] Clinical practice around blood transfusion therapy is also framed around correcting specific pathophysiologic deficits (e. ^[7][46] g. , anemia, coagulopathy) rather than just alleviating subjective fatigue or dyspnea. Colchicine use in pericarditis is guided by evidence that it reduces recurrence by acting on the inflammatory process, not just pain, which illustrates treating sources of symptoms. ^[8] Methodological frameworks like GRADE explicitly distinguish symptom relief from outcomes that reflect underlying disease modification and prioritize the latter when rating quality of evidence and making recommendations. ^[6][44]

Contradicts

The claim, stated broadly, risks implying that treating symptoms is intrinsically inferior or should be abandoned, which is not supported by mainstream evidence. ^[6] Major guidelines consistently combine symptom control with etiologic and risk-factor management rather than insisting that care must always move “beyond” symptoms. ^[2] For tension-type headache, the EFNS guideline explicitly recommends symptomatic analgesic and nonpharmacologic therapies while also addressing triggers and comorbidities, reflecting an integrated rather than symptoms-versus-causes framing. ^{[4][43][45][46]} In pericarditis, colchicine and NSAIDs are used both to control symptoms (pain, inflammation) and to prevent recurrence; the evidence does not support neglecting symptom treatment while pursuing only underlying mechanisms. ^[8][44] Blood transfusion and parenteral nutrition guidelines likewise acknowledge that supportive and symptomatic treatments are sometimes primary, especially when the underlying cause cannot be rapidly reversed. ^[5][7] The claim also overlooks settings such as palliative care and end-of-life medicine, where symptom-focused treatment is a core, evidence-backed goal and “moving beyond treating symptoms” is neither realistic nor ethical.

Mainstream view

The mainstream medical and scientific position is that high-quality care should include both: accurate diagnosis and management of underlying causes and pathophysiologic processes, and appropriate, evidence-based symptomatic relief. ^{[1][5][6][44][46]} Guidelines for hypertension, nutrition support, inflammatory bowel disease, tension-type headache, and pericarditis all stress identifying etiologic factors and using disease-modifying or risk-factor–targeted interventions alongside structured symptomatic management. ^{[2][3][4][8][43]} Symptom-only treatment is considered insufficient when effective etiologic therapies or risk-factor interventions exist, but symptomatic therapies remain indispensable to reduce suffering, improve quality of life, and sometimes prevent complications while etiologic treatment is underway or unavailable. ^[45] Therefore, the mainstream view is not to “move beyond” symptoms in a way that devalues them, but to integrate symptom control with identification and treatment of underlying sources whenever possible.

In their own wordsView sourceArchived copy

“we move beyond treating symptoms to identifying and treating their sources”

Rule: Minnesota Chiropractic Practice Act (scope limited to musculoskeletal/spine care)